CID 71113742

Sovleplenib

Structural Information

Molecular Formula
C24H30N6O3S
SMILES
CS(=O)(=O)N1CCC(CC1)C2=CC=C(C=C2)C3=CC4=NC=CN=C4C(=N3)NC[C@@H]5CNCCO5
InChI
InChI=1S/C24H30N6O3S/c1-34(31,32)30-11-6-18(7-12-30)17-2-4-19(5-3-17)21-14-22-23(27-9-8-26-22)24(29-21)28-16-20-15-25-10-13-33-20/h2-5,8-9,14,18,20,25H,6-7,10-13,15-16H2,1H3,(H,28,29)/t20-/m0/s1
InChIKey
NJIAKNWTIVDSDA-FQEVSTJZSA-N
Compound name
7-[4-(1-methylsulfonylpiperidin-4-yl)phenyl]-N-[[(2S)-morpholin-2-yl]methyl]pyrido[3,4-b]pyrazin-5-amine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

8125
Patents

482.21002 Da
Monoisotopic Mass

1.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 483.21730 210.4
[M+Na]+ 505.19924 223.2
[M+NH4]+ 500.24384 215.1
[M+K]+ 521.17318 215.2
[M-H]- 481.20274 216.6
[M+Na-2H]- 503.18469 217.5
[M]+ 482.20947 214.2
[M]- 482.21057 214.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe